Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling AA Alizadeh, MB Eisen, RE Davis, C Ma, IS Lossos, A Rosenwald, ... Nature 403 (6769), 503-511, 2000 | 12555 | 2000 |
Robust enumeration of cell subsets from tissue expression profiles AM Newman, CL Liu, MR Green, AJ Gentles, W Feng, Y Xu, CD Hoang, ... Nature methods 12 (5), 453-457, 2015 | 9382 | 2015 |
Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. R Radha, S Jayalakshmi, SP Rajagopalan, AA Alizadeh, MB Eisen, ... Information Technology Journal 7 (1), 503-511, 2000 | 4444 | 2000 |
Comparison of discrimination methods for the classification of tumors using gene expression data S Dudoit, J Fridlyand, TP Speed Journal of the American statistical association 97 (457), 77-87, 2002 | 3572 | 2002 |
The prognostic landscape of genes and infiltrating immune cells across human cancers AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim, VS Nair, ... Nature medicine 21 (8), 938-945, 2015 | 2854 | 2015 |
Determining cell type abundance and expression from bulk tissues with digital cytometry AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ... Nature biotechnology 37 (7), 773-782, 2019 | 2749 | 2019 |
Profiling tumor infiltrating immune cells with CIBERSORT B Chen, MS Khodadoust, CL Liu, AM Newman, AA Alizadeh Methods in molecular biology (Clifton, NJ) 1711, 243, 2018 | 2358 | 2018 |
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ... Nature medicine 20 (5), 548-554, 2014 | 2233 | 2014 |
Genome-wide anaIysis of DNA copy-number changes using cDNA microarrays JR Pollack, CM Perou, AA Alizadeh, MB Eisen, A Pergamenschikov, ... Nature genetics 23, 1999 | 2040 | 1999 |
CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells R Majeti, MP Chao, AA Alizadeh, WW Pang, S Jaiswal, KD Gibbs, ... Cell 138 (2), 286-299, 2009 | 1833 | 2009 |
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors SB Willingham, JP Volkmer, AJ Gentles, D Sahoo, P Dalerba, SS Mitra, ... Proceedings of the National Academy of Sciences 109 (17), 6662-6667, 2012 | 1618 | 2012 |
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ... The Journal of experimental medicine 194 (11), 1639-1648, 2001 | 1443 | 2001 |
Diversity, topographic differentiation, and positional memory in human fibroblasts HY Chang, JT Chi, S Dudoit, C Bondre, M van de Rijn, D Botstein, ... Proceedings of the National Academy of Sciences 99 (20), 12877-12882, 2002 | 1396 | 2002 |
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma MP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ... Cell 142 (5), 699-713, 2010 | 1166 | 2010 |
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds HY Chang, JB Sneddon, AA Alizadeh, R Sood, RB West, K Montgomery, ... PLoS Biol 2 (2), e7, 2004 | 1166 | 2004 |
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes IS Lossos, DK Czerwinski, AA Alizadeh, MA Wechser, R Tibshirani, ... New England Journal of Medicine 350 (18), 1828-1837, 2004 | 1093 | 2004 |
Integrated digital error suppression for improved detection of circulating tumor DNA AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ... Nature biotechnology 34 (5), 547-555, 2016 | 1075 | 2016 |
Individuality and variation in gene expression patterns in human blood AR Whitney, M Diehn, SJ Popper, AA Alizadeh, JC Boldrick, DA Relman, ... Proceedings of the National Academy of Sciences 100 (4), 1896, 2003 | 927 | 2003 |
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 862 | 2020 |
Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47 MP Chao, S Jaiswal, R Weissman-Tsukamoto, AA Alizadeh, AJ Gentles, ... Science translational medicine 2 (63), 63ra94-63ra94, 2010 | 826 | 2010 |